510(k) K170247
K170247 is an FDA 510(k) premarket notification submitted by Kaneka Pharma America, LLC for the device "Lacriflow CL". The FDA issued a decision of Substantially Equivalent on Apr 18, 2017. The device falls under product code OKS (Lacrimal Stents And Intubation Sets), a Class U device. Kaneka Pharma America, LLC has 3 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 18, 2017
- Date Received
- Jan 27, 2017
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Lacrimal Stents And Intubation Sets
- Device Class
- Class U
- Review Panel
- OP
- Submission Type
- 510(k)
Lacrimal stents and intubations sets are intended to repair the lacrimal drainage system. Lacrimal stents and intubations sets are indicated for, but limited to, the treatment of epiphora in infants and adults; canalicular pathologies such as stenosis; obstruction or laceration; and conditions requiring dacryocystorhinostomy (conventional or laser); or imperforation of the nasolacrimal duct in an infant.
Need the full FDA record for Kaneka Pharma America, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.